SOUS FORME CRISTALLINE II DE 3-ETHYLE -4-{3-ISOPROPYL-4-(4-(1-METHYLE-1H-PYRAZOL- 4-YL)-1H-IMIDAZOLE-1-YL)-1HPYRAZOL0[3,4-B]PYRIDIN-1-YL} BENZAMIDE

• 收藏
• 分享

专利权人:

TAIHO PHARMACEUTICAL CO.; LTD.

发明人:

UNO, TAKAO

申请号：

CA2985033

公开号：

CA2985033A1

申请日:

2016.05.11

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

Provided are crystals of 3-ethyl-4-{3-isopropyl-4-(4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl}benzamide which are stable and have excellent oral absorbability. The crystals are II-form crystals of 3-ethyl-4-{3-isopropyl-4-(4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl}benzamide which are characterized by giving an X-ray powder diffraction spectrum which has characteristic peaks at at least three diffraction angles (2?±0.2º) selected from among 7.7º, 8.0º, 11.1º, 12.5º, 12.9º, 15.2º, 15.8º, 17.2º, 19.0º, 22.5º, 26.1º, and 27.4º.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/